HomeLVZPF • OTCMKTS
add
Livzon Pharmaceutical Group Inc
Previous close
$3.43
Year range
$3.28 - $3.60
Market cap
30.11B HKD
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 3.18B | -1.92% |
Operating expense | 1.21B | -8.33% |
Net income | 636.71M | 4.75% |
Net profit margin | 20.02 | 6.83% |
Earnings per share | — | — |
EBITDA | 996.75M | 1.13% |
Effective tax rate | 16.16% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.90B | -2.96% |
Total assets | 24.49B | -2.80% |
Total liabilities | 9.11B | -6.57% |
Total equity | 15.38B | — |
Shares outstanding | 894.67M | — |
Price to book | 0.22 | — |
Return on assets | 8.78% | — |
Return on capital | 11.27% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 636.71M | 4.75% |
Cash from operations | 724.73M | -21.59% |
Cash from investing | -221.75M | 51.51% |
Cash from financing | -487.92M | 25.47% |
Net change in cash | 3.63M | 101.93% |
Free cash flow | 29.24M | -89.99% |
About
Founded
Jan 26, 1985
Website
Employees
9,067
